Latest Developments on API Self-Reliance India has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines to countries across the globe. However, despite its...
Key Highlights: Implications: Zydus’ smart-pen assault smashes generic pricing barriers, handing endocrinologists flexible dosing that trumps competitor pens while exploding Tier-2 a...
Key Highlights: Implications: Semaglutide generics could slash Novo Nordisk pricing by 70-80% in India’s $2.5B diabetes market (12% CAGR), capturing 25%+ share and pressuring chronic...
Key Highlights: Implications: StopBleed fills critical gap in India’s trauma response, handing emergency teams a game-changing tool that slashes preventable bleeding death...
Dr. Reddy’s Laboratories Acquires Progynova and Cyclo-Progynova Trademarks from Mercury Pharma Group
Key Highlights: Implications: Dr. Reddy’s gains immediate leadership in the estradiol segment, leveraging its physician network to rapidly expand gynecology prescriptions...
Key Highlights: Implications: Anyra smashes Eylea pricing barriers, flooding retina clinics with budget-friendly therapy that keeps patients compliant for years. Zydus seizes op...
Key Highlights: Implications: Lilly’s India manufacturing bet locks in low-cost production muscle, outflanking China-dependent rivals as Mounjaro mania drives capacit...
Key Highlights: Implications: CANTAB’s India entry taps the $1B+ digital diagnostics market (25% CAGR), challenging manual screening while accelerating early dementia detection amid ...
Mango Sciences Inc. Partners with ImmunoAdoptive Cell Therapy to Improve Access to NexCAR19 in India
Key Highlights: Implication: This financing model slashes NexCAR19’s effective cost by 30-40%, challenging global CAR-T players like Novartis/Kite while accelerating adoption in Tier...
